Two Sigma Investments, LP Metacrine, Inc. Put Options Transaction History
Two Sigma Investments, LP
- $42.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MTCR
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About Metacrine, Inc.
- Ticker MTCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,569,500
- Description
- Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.